Ferroptosis-mediated osteoclast-osteoblast crosstalk: signaling pathways governing bone remodeling in osteoporosis

DuJiang Yang, Guozhong Gong, Ji-Young Song, Junjie Chen, Shuang Wang, Jingchi Li, GuoYou WangJournal of Orthopaedic Surgery and Research 2025 · DOI

TL;DR

This review highlights ferroptosis, a form of programmed cell death driven by lipid peroxidation, as a critical player in osteoporosis. By detailing the molecular pathways involved, the authors propose targeting ferroptosis as a novel therapeutic strategy to restore bone health and combat this widespread bone disease.

What Problem Does This Paper Address?

Osteoporosis is a major global health concern characterized by weakened bones, leading to increased fracture risk. While the imbalance between bone-forming osteoblasts and bone-resorbing osteoclasts is well-established, the precise molecular mechanisms driving this imbalance in osteoporosis remain an active area of research. This paper addresses the emerging role of ferroptosis, a less-understood cell death pathway, in disrupting the delicate crosstalk between osteoblasts and osteoclasts, ultimately contributing to bone loss and the progression of osteoporosis. Understanding these mechanisms is crucial for developing more effective treatments.

Methods

This paper is a comprehensive review, synthesizing existing research rather than presenting new experimental data. The authors meticulously analyze and integrate findings from numerous studies to delineate the complex signaling pathways and molecular players involved in ferroptosis within the context of bone remodeling and osteoporosis. They focus on key pathways such as the Xc-GSH-GPX4 axis, the FSP1-CoQ10-NADPH pathway, and the DHODH-CoQ10 pathway, as well as critical molecules like TFR1, FPN, and ALOX15. The review employs a narrative synthesis approach, drawing connections between molecular mechanisms, cellular functions, and pathological outcomes in osteoporosis.

Datasets

Not discussed in the paper. This is a review article, not an experimental study with datasets.

Key Insights and Ideas

  • Ferroptosis as a Central Player: The paper strongly posits that ferroptosis is not just a bystander but a key driver in osteoporosis, directly impacting the balance of bone remodeling.
  • Iron Overload's Vicious Cycle: Elevated iron levels, a common feature in aging and certain conditions, can trigger the Fenton reaction, leading to excessive reactive oxygen species (ROS). This ROS then fuels lipid peroxidation, a hallmark of ferroptosis, creating a self-perpetuating cycle of cellular damage and death.
  • Osteoblast-Osteoclast Crosstalk Disruption: Ferroptosis dysregulation specifically impairs osteoblast function (bone formation) and promotes osteoclast activity (bone resorption), directly contributing to bone loss.
  • Multiple Pathways Converge on Ferroptosis: The review details several interconnected pathways (e.g., Xc-GSH-GPX4, FSP1-CoQ10-NADPH) that, when disrupted, can lead to ferroptosis and negatively impact bone health.
  • Targeting Ferroptosis as a Therapeutic Avenue: The authors propose that modulating ferroptosis pathways, rather than just addressing calcium or vitamin D deficiencies, offers a novel and promising strategy for treating osteoporosis.

Key Results

The paper doesn't present quantitative results in the traditional sense, as it's a review. However, the key "results" are the synthesized insights:

  • Mechanism of Ferroptosis in Osteoporosis: The review clearly outlines how iron overload, ROS production, GPX4 inactivation, and subsequent lipid peroxidation cascade lead to ferroptotic cell death in bone cells.
  • Molecular Signatures: It identifies critical molecules (TFR1, FPN, ALOX15, GPX4, FSP1, CoQ10) and pathways (Xc-GSH-GPX4, FSP1-CoQ10-NADPH, DHODH-CoQ10) that are dysregulated in osteoporosis and contribute to ferroptosis.
  • Cellular Impact: Ferroptosis leads to impaired osteoblast mineralization and function, while simultaneously enhancing osteoclast activity and bone resorption.
  • Therapeutic Potential: The review strongly suggests that interventions targeting ferroptosis pathways hold significant promise for restoring bone homeostasis and treating osteoporosis.

Limitations and Future Work

The authors acknowledge several areas for future investigation:

  • Unresolved Questions in Clinical Treatment: There's a need for further research into how ferroptosis is precisely regulated in clinical osteoporosis and how to best target it therapeutically.
  • Precision Delivery Systems: Developing targeted delivery systems for ferroptosis modulators is crucial to minimize off-target effects and maximize efficacy.
  • Integration of Advanced Technologies: The authors advocate for integrating cutting-edge technologies like molecular activators, precision delivery systems, and multi-omics approaches to advance ferroptosis-targeted therapies.
  • Spatial and Temporal Regulation: Future studies should focus on the spatial (subcellular localization) and temporal (disease stage specificity) aspects of ferroptosis regulation.
  • Immune-Metabolic Crosstalk: Investigating the intricate interplay between immune cells, metabolism, and ferroptosis in the bone marrow niche is highlighted as a critical future direction.

Summary updated

Abstract

This review synthesizes recent advances, delineating core pathways(e.g., Xc-GSH-GPX4 axis, FSP1-CoQ10-NADPH, and DHODH-CoQ10 and key molecules (TFR1, FPN, ALOX15) regulating osteoporosis. We emphasize that ferroptosis dysregulation in osteoblasts and osteoclasts disrupts cellular redox balance, impairing bone microstructure and biomechanical strength, thereby accelerating osteoporosis progression. Mechanistically, iron overload promotes ROS production via the Fenton reaction, inactivates GPX4, and triggers a lipid peroxidation cascade. Targeting ferroptosis represents a novel governing strategy to restore bone homeostasis. We discuss unresolved questions regarding ferroptosis regulation in clinical osteoporosis treatment and outline future prospects involving molecular activators, precision delivery systems, and integration of cutting-edge technologies, providing a theoretical foundation for basic research and clinical applications.
BibTeX
@article{yang2025ferroptosis,
  author = {DuJiang Yang and Guozhong Gong and Ji-Young Song and Junjie Chen and Shuang Wang and Jingchi Li and GuoYou Wang},
  title = {{Ferroptosis-mediated osteoclast-osteoblast crosstalk: signaling pathways governing bone remodeling in osteoporosis}},
  journal = {Journal of Orthopaedic Surgery and Research},
  year = {2025},
  doi = {10.1186/s13018-025-06315-9},
}
Figure